2/5/2026CDE Issues Trial Guideline for Neuropathic Pain Drug Development

2/5/2026CDE Issues Technical Guideline for Clinical Trials of Chronic Insomnia...

2/3/2026NMPA Logs Wave of Novel Drug Approvals and Clinical Trial Clearances L...

2/3/2026China and USFDA Officials Pledge to Deepen Regulatory Cooperation at B...

1/30/2026China Solicits Comments on 103rd Batch of Reference Formulations for C...

1/30/2026China Releases New Guideline on CMC Changes for Cell Therapy Products

1/30/2026CDE Issues New Clinical Trial Guideline for Antifibrotic Drugs in Inte...

1/30/2026CDE Issues Trial Guideline to Standardize Clinical Development of Anti...

1/28/2026CDE Issues New Technical Guidance for Clinical Trials of Long-Acting L...

1/28/2026NMPA Releases 101st Batch of Reference Formulations for Generic Drug E...

1/27/2026China Issues Revised Implementing Regulations for the Drug Administrat...

1/27/2026NMPA Adopts ICH M14 Guideline on Real-World Evidence for Drug Safety E...

1/26/2026CDE Issues Technical Guidance on NMR Studies for Glycoconjugate Vaccin...

1/26/2026NMPA Suspends Import, Sale and Use of Sun Pharma's Rivastigmine Capsul...

1/26/2026NMPA Suspends Import and Use of Chlorpheniramine Maleate API from Supr...

1/23/2026CDE Seeks Public Feedback on Draft ICH E22 Guideline on Patient Prefer...

1/23/2026CDE Invites Public Comment on Draft Guideline for Physicochemical and ...

1/22/2026China Unveils New Policy to Transform Pharmacies into Community Health...

1/22/2026CDE Seeks Public Input on Draft Guidance for Risk Assessment and Contr...

1/22/2026NMPA Issues New Guidance to Standardize Vaccine Adjuvant Research, Boo...

1/21/2026CDE Issues Draft Guidance on Using Bayesian External Data in Drug Clin...

1/19/2026NMPA Announces Adoption of ICH Q8/Q9/Q10 Q&A (R5) Guidelines for Drug ...

1/16/2026China's NMPA to Mandate eCTD Submission Starting March 1

1/9/2026NHSA Seeks Comments on Draft Rules for Early Communication on Comparat...

1/9/2026China Issues New Procedures for Post-Approval Filing Changes to Overse...

1/8/2026China Outlines 2026 Drug Regulatory Priorities with Focus on Safety, I...

1/8/2026China Revises Drug Administration Law Implementation Rules to Boost In...

1/8/2026China to Implement ICH E6(R3) Guideline for Drug Clinical Trial Qualit...

1/8/2026NMPA Clarifies Application of ICH Q12 to Strengthen Pharmaceutical Lif...

1/8/2026NMPA Moves to Accelerate Approval of Overseas-Approved Drugs for Urgen...

Page:1/8 Total number of articles:224: [First][<<] [1] [2] [3] [4] [5] [>>] [End]